Professional Documents
Culture Documents
PUBHEALTH
PUBHEALTH
BORNE DISEASES
09-30-2015
Objectives
At the end of the lesson the
student should be able to:
Objectives
At the end of the lesson the
student should be able to:
Objectives
At the end of the lesson the
student should be able to:
5.
VECTORBORNE
DENGUE FEVER
VECTORBORNE
DENGUE
FEVER
VECTORDENGUE
FEVER
BORNE
Occurrence: (DOH, 2015)
Jan.-May, 2015: reported suspected
dengue cases 22, 903 cases
*8% higher than the same period last
year
Most cases:
CALABARZON
VECTORBORNE
DENGUE
FEVER
VECTORBORNE
DENGUE
FEVER
SYMPTOMS:
- Appear 3-14 days after infective bite
- Symptoms range from mild fever- to
incapacitating high fever (40C/104F)
- Severe headache, pain behind the
eyes, muscle and joint pain; rash
VECTORBORNE
DENGUE
FEVER
VECTORBORNE
DENGUE
FEVER
VECTORBORNE
DENGUE
FEVER
VECTORBORNE
DENGUE
FEVER
TRANSMISSION:
Indirect contact: Transmitted by the bite
of a female mosquito infected with one
of the four dengue virus serotypes.
Primary Vector: Aedes aegypti
Carrier & multiplier: Infected humans
source of the virus for uninfected
mosquitoes.
VECTORBORNE
Vector:
DENGUE
FEVER
Aedes aegypti
- Lives in urban habitats and breeds mostly
in man-made containers.
- Day-time feeder
- Peek biting period: early in the morning
and in the evening before dusk
- Bites multiple people during each feeding
period.
VECTORBORNE
Vector:
DENGUE
FEVER
Aedes albopictus
- Secondary dengue vector.
- Highly adaptive and can survive in cooler
temperate regions
- It spread is due to its tolerance to
temperature below freezing point,
hibernation and ability to shelter in
microhabitats
VECTORBORNE
DENGUE
FEVER
TREATMENT:
There is no specific treatment
For severe dengue:
- Maintenance of the patients body fluid
volume is critical.
VECTORDENGUE
FEVER
BORNE
IMMUNIZATION:
- There is no vaccine yet
- Three tetravalent live-attenuated
vaccines: under development in phase
II and phase III clinical trials
- 3 other vaccine candidates ( based
on subunit, DNA and purified
inactivated virus platforms):
At earlier stages of clinical development.
VECTORDENGUE
FEVER
BORNE
PREVENTION AND CONTROL:
(WHO May,
2015)
VECTORDENGUE
FEVER
BORNE
Covering, emptying and cleaning of
domestic water storage containers
on a weekly basis;
Applying appropriate insecticides to
water storage outdoor containers;
Using personal household protection
such as window screens, longsleeved clothes, insecticide treated
materials, coils and vaporizers;
VECTORBORNE
DENGUE
FEVER
Improving community participation and
mobilization for sustained vector
control;
Applying insecticides as space spraying
during outbreaks as one of the
emergency vector-control measures;
Active monitoring and surveillance of
vectors should be carried out to
determine effectiveness of control
interventions.
VECTORDENGUE
FEVER
BORNE
PREVENTION AND CONTROL: (DOH 2015)
June is dengue awareness month
Theme: Eskwelahan, Simbahan,
Barangay, Palengke at Buong
Komunidad, Sama-Sama Nating
Sugpuin ang Dengue
Aims: to heighten awareness of the
strategy to fight dengue by
adopting 4S Kontra Dengue.
VECTORDENGUE
FEVER
BORNE
PREVENTION AND CONTROL: (DOH 2015)
DOH 4S Kontra Dengue Strategy
VECTORDENGUE
FEVER
BORNE
PREVENTION AND CONTROL: (DOH 2015)
DOH Advisory:
Destroy all possible breeding sites
like old tires and tin cans, clean roof
gutters, replace water in flower
vases regularly and to use mosquito
nets or protective clothing
Fogging may be done only in
outbreak areas.
VECTORDENGUE
FEVER
BORNE
Protect yourself from day bites by
using topical insect repellants or
wearing long-sleeved shirts
Seek treatment if there are
persistently high fever,
appearance of skin rashes or any
signs of bleeding.
VECTORBORNE
MALARIA
VECTORBORNE
MALARIA
parasite
Plasmodium falciparum
Plasmodium vivax
Plasmodium malariae
Plasmodium ovale
Vector: Anopheles mosquitoes
Bite: between dusk and dawn
VECTORBORNE
MALARIA
VECTORMALARIA
BORNE
Occurrence: (DOH, March 11, 2014)
Note: Malaria cases declined
since the mid-2000s
83% reduction from 2005-2013
92% reduction in the # of deaths
Number of cases went down:
2005: 46, 342 cases 2013: 7,
720 cases
VECTORMALARIA
BORNE
Occurrence: (DOH, March 11, 2014)
2005: 150 deaths 2013: 12
deaths
Note: Achieved MDG target for
2015 as early as 2008.
Of 53 known provinces (endemic)
27 have already declared
malaria-free.
VECTORMALARIA
BORNE
TRANSMISSION: (WHO, April, 2015)
Malaria is transmitted exclusively
through the bites of
Anopheles mosquitoes. The
intensity of transmission
depends on factors related to
the parasite, the vector, the
human host, and the
environment.
VECTORBORNE
MALARIA
VECTORBORNE
MALARIA
VECTORBORNE
MALARIA
VECTORBORNE
MALARIA
VECTORBORNE
MALARIA
The choice of
artemisinin combination
therapy (ACT)
mefloquine
artemisinin ++ piperaquine
amodiaquine
mefloquine
artemether + lumefantrine
mefloquine
sulfadoxinepyrimaethaminine
artesunate ++
mefloquine
dihydroartemisinin + piperaquine
naphthoquine
proguanil-dapsone
chlorproguanil-dapsone
atovaquone-proguanil
clindamycin
tetracycline
doxycycline
VECTORBORNE
MALARIA
VECTORBORNE
MALARIA
Prevention:
- Vector control is the main
way to reduce malaria
transmission at the
community level.
- For individuals, personal
protection against mosquito
bites as first line of defense.
VECTORBORNE
MALARIA
Prevention:
- Two forms of vector control:
Insecticide-treated mosquito nets
(ITNs)
a. Long-lasting insecticidal nets
(LLINs) are the preferred form of ITNs
for public health distribution programs.
b. Indoor residual spraying (IRS)
with insecticides- is a powerful way
to rapidly reduce malaria transmission.
VECTORBORNE
MALARIA
Prevention:
b. Indoor residual spraying (IRS)
with insecticides
- Indoor spraying: effective for 3-6
months
- Pyrethroids: (insecticides) mosquito
resistance
VECTORBORNE
MALARIA
Prevention:
- Vaccines
- No licensed vaccines yet.
- RTS, S/AS01: under research vaccine
against
P. falciparun
ADDITIONAL
INFORMATION
OTHER INFECTIOUS
JAPANESE
ENCEPHALITIS
DISEASES
09-30-2015
VECTORBORNE
JAPANESE
ENCEPHALITIS
CHARACTERISTICS:
- Type of viral brain infection
- Spread through mosquito bites:
Culex tritaeniorhynchus
- Common in rural areas throughout
South East Asia, the Pacific islands
and the Far East
- Rare in travellers
VECTORBORNE
JAPANESE
ENCEPHALITIS
CHARACTERISTICS:
- Flavivirus related to dengue,
yellow fever and West Nile
viruses
- Symptomatic
- rare: case-fatality rate can be
high as 30%
- No cure for the disease
VECTORJAPANESE
ENCEPHALITIS
BORNE
CHARACTERISTICS:
- host: pigs and birds while humans
are incidental or dead-end hosts
- Treatment is focused on relieving
severe clinical signs and
supporting the patient to
overcome infection.
- Safe and effective vaccines are
available.
VECTORBORNE
JAPANESE
ENCEPHALITIS
End